Time: 8:30-10:00 am
Location: Mid-America Regional Council, 600 Broadway Blvd #200, Kansas City, MO 64105, USA
Admission: Free
We have two presentations scheduled for our November meeting.
First we will hear from Naveen Gogumalla, the CEO of NthJEN. Naveen is a strategic business leader with 30 year of experience in the Healthcare, Telecommunications and Financial industries where his focus has been on building programs and business units. He earned a Bachelors of Science degree with a focus on Marketing and Computer Information Systems and a MBA with a focus on Strategic Ethical Leadership from the University of Central Missouri.
NthJEN expresses its company vision as: “Your Health in Your Hands” – We know what we need to do to be healthy, stay healthy and live well! Incentivizing the behavior will engage the patient at a deeper level. MEIDIDOC is a true patient engagement platform that uses Wearables and Reward Based Programs to promote healthy living. Patient behavior is tracked between visits using sensors, positive behaviors are rewarded with points and these points can be redeemed to reduce healthcare costs.
Our next presenters are Bob Etzel and Christa Anderson PhD from Nascent Stage Research and Development (NSR&D). Bob is known nationally for his work in technology education and is a senior leader in Kansas City healthcare applications and technologies. He was recognized in October by MU Chancellor Alexander Cartwright at the university’s annual innovation luncheon for his work in healthcare technology transfer for the university. Christa is a Neurocognitive Autism Scientist. She is a pioneer in her work using pupillometry to detect and improve neurological characterization in those with Autism Spectrum Disorders (ASD).
NSR&D is a KCMO based LLC whose mission is to radically improve the way people with ASD live by teaming innovative university researchers with cutting edge technologists. Bob will provide a brief description of the four strategic business units at NSR&D. Christa will provide details on the fourth business unit, the MU and NSR&D program on Pupillary Light Reflex (PLR). PLR has been used by this team to accurately detect developmental disabilities (DD) and ASD in children as young as 6 months of age. Detecting the presence of DD and ASD in infancy is known to dramatically improve behavioral and cognitive outcomes in those with these disorders due to the ability to provide behavioral and pharmacological interventions much earlier in life.